KR840002242A - 담석증 치료약 - Google Patents

담석증 치료약 Download PDF

Info

Publication number
KR840002242A
KR840002242A KR1019820005368A KR820005368A KR840002242A KR 840002242 A KR840002242 A KR 840002242A KR 1019820005368 A KR1019820005368 A KR 1019820005368A KR 820005368 A KR820005368 A KR 820005368A KR 840002242 A KR840002242 A KR 840002242A
Authority
KR
South Korea
Prior art keywords
drug
subject
treating cholelithiasis
cholelithiasis according
treating
Prior art date
Application number
KR1019820005368A
Other languages
English (en)
Inventor
이쿠오 니시시사와
Original Assignee
미야이리 히사가즈
미야리상 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미야이리 히사가즈, 미야리상 가부시키 가이샤 filed Critical 미야이리 히사가즈
Priority to KR1019820005368A priority Critical patent/KR840002242A/ko
Publication of KR840002242A publication Critical patent/KR840002242A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음.

Description

담석증 치료약
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 동물 또는 사람의 분변(糞便)으로부터 분리한 장내에 상존하는 균 및 장내에서 발육 가능한 균을 주제로 하는 담석증 치료약.
  2. 제1항에 있어서, 상기 주제를 클로스트리디움 부티리컴(Clostridium butyricum)으로 하는 것을 특징으로 하는 담석증 치료약.
  3. 제1항에 있어서, 상기 주제를 클로스트리디움 스페노이드(Clostridium Sphenoides)로하는 것을 특징으로 하는 담석증 치료약
  4. 제1항에 있어서, 상기 주제를 박테로이드 프레기리스(Bacteroides fragilis)로 하는 것을 특징으로 하는 담석증 치료약.
  5. 제1항에 있어서, 상기 주제를 박테로이드 물티아시더스(Bacteroides Multiacidus)로 하는 것을 특징으로 하는 담석증 치료약.
  6. 제1항에 있어서, 상기 주제를 비피도박테리움 아도레스센티스(Bifidobacterium adolescentis)로 하는 것을 특징으로 하는 담석증 치료약.
  7. 제1항에 있어서, 상기 주제를 비피도박테리움 롱검(Bifidobacterium longum)로 하는 것을 특징으로 하는 담석증 치료약.
  8. 제1항에 있어서, 상기 주제를 락토바실러스 브레비스(Lacotacillus brevis)로 하는 것을 특징으로 하는 담석증 치료약.
  9. 제1항에 있어서, 상기 주제를 락토바실러스 프랜타름(Lacotacillus plantarum)로 하는 것을 특징으로 하는 담석증 치료약.
  10. 제1항에 있어서, 상기 주제를 이시리시이 코리(Esherichi coli)로 하는 것을 특징으로 하는 담석증 치료약.
  11. 제1항에 있어서, 상기 주제를 스트렙토코커스 페카리스(Streptococcus faecalis)로 하는 것을 특징으로 하는 담석증 치료약.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019820005368A 1982-11-30 1982-11-30 담석증 치료약 KR840002242A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019820005368A KR840002242A (ko) 1982-11-30 1982-11-30 담석증 치료약

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019820005368A KR840002242A (ko) 1982-11-30 1982-11-30 담석증 치료약

Publications (1)

Publication Number Publication Date
KR840002242A true KR840002242A (ko) 1984-06-25

Family

ID=57210032

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019820005368A KR840002242A (ko) 1982-11-30 1982-11-30 담석증 치료약

Country Status (1)

Country Link
KR (1) KR840002242A (ko)

Similar Documents

Publication Publication Date Title
ATE42338T1 (de) Hefe des genus kluyveromyces, modifiziert zur expression von preprothaumatin oder seinen verschiedenen allelischen und modifizierten formen oder maturationsformen.
SE7909492L (sv) Mikroorganismpreparat
DE3689974D1 (de) Arzneimittel zur Behandlung von Emesis.
DE3575296D1 (de) Pyrazolkarboxamidabkoemmlinge, deren herstellung und diese enthaltende bakterientoetende mittel.
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
DE69014030T2 (de) Mittel für die Verhütung und Behandlung von Diarrhöe.
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
LU90386I2 (fr) Quadrasa
FR2450108B1 (fr) Agent antitumoral contenant la souche lactobacillus casei yit 9018
DE58904683D1 (de) Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
DE69228738D1 (de) Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
FR2491334B1 (ko)
DE3850433T2 (de) Allergiebehandlung und Zusammensetzung dafür.
DE3853859D1 (de) Videoeffektsystem mit videowiederholmischung und ausgangsmischung.
FR2675020B1 (fr) Produit solide contenant des composants de propolis, preparation et applications.
FR2659658B1 (fr) Silice traitee par un organosilicone et composition la contenant.
KR840002242A (ko) 담석증 치료약
DE3881099D1 (de) Acrylkautschuk, zusammensetzung aus acrylkautschuk und gegenstaende aus vernetztem acrylkautschuk.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
JPS51121521A (en) Deodorant compositions
CH535588A (de) Gerät zur ärztlichen Behandlung von Gelenken, Muskeln, des Nervensystems oder anderen Teilen von Lebewesen
ES507686A0 (es) Procedimiento para reducir el contenido residual total de epihalohidrina y 1,3-dihalo-2-propanol combinados.
STERNBERG THE COMPONENTIAL ANALYSIS OF HUMAN ABILITIES: INTELLIGENCE, INFORMATION PROCESSING, AND ANALOGICAL REASONING.(VOLUMES 1 AND 2)